<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xu C</submitter><funding>Science and Technology Program of Guangzhou</funding><funding>National Natural Science Foundation of China</funding><funding>Natural Science Foundation of Guangdong Province</funding><funding>Clinical Research Program of Nanfang Hospital</funding><pagination>458-466</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7818264</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>128(2)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To predict fetal growth restriction (FGR) by whole-genome promoter profiling of maternal plasma.&lt;h4>Design&lt;/h4>Nested case-control study.&lt;h4>Setting&lt;/h4>Hospital-based.&lt;h4>Population or sample&lt;/h4>810 pregnancies: 162 FGR cases and 648 controls.&lt;h4>Methods&lt;/h4>We identified gene promoters with a nucleosome footprint that differed between FGR cases and controls based on maternal plasma cell-free DNA (cfDNA) nucleosome profiling. Optimal classifiers were developed using support vector machine (SVM) and logistic regression (LR) models.&lt;h4>Main outcome measures&lt;/h4>Genes with differential coverages in promoter regions through the low-coverage whole-genome sequencing data analysis among FGR cases and controls. Receiver operating characteristic (ROC) analysis (area under the curve [AUC], accuracy, sensitivity and specificity) was used to evaluate the performance of classifiers.&lt;h4>Results&lt;/h4>Through the low-coverage whole-genome sequencing data analysis of FGR cases and controls, genes with significantly differential DNA coverage at promoter regions (-1000 to +1000 bp of transcription start sites) were identified. The non-invasive 'FGR classifier 1' (C&lt;sub>FGR&lt;/sub> 1) had the highest classification performance (AUC, 0.803; 95% CI 0.767-0.839; accuracy, 83.2%) was developed based on 14 genes with differential promoter coverage using a support vector machine.&lt;h4>Conclusions&lt;/h4>A promising FGR prediction method was successfully developed for assessing the risk of FGR at an early gestational age based on maternal plasma cfDNA nucleosome profiling.&lt;h4>Tweetable abstract&lt;/h4>A promising FGR prediction method was successfully developed, based on maternal plasma cfDNA nucleosome profiling.</pubmed_abstract><journal>BJOG : an international journal of obstetrics and gynaecology</journal><pubmed_title>Non-invasive prediction of fetal growth restriction by whole-genome promoter profiling of maternal plasma DNA: a nested case-control study.</pubmed_title><pmcid>PMC7818264</pmcid><funding_grant_id>201604020104</funding_grant_id><funding_grant_id>2018A030313286</funding_grant_id><funding_grant_id>81871177</funding_grant_id><funding_grant_id>201803040009</funding_grant_id><funding_grant_id>2018CR039</funding_grant_id><pubmed_authors>Lv Z</pubmed_authors><pubmed_authors>Guo Z</pubmed_authors><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Xu C</pubmed_authors><pubmed_authors>Liu S</pubmed_authors><pubmed_authors>Li K</pubmed_authors><pubmed_authors>Wang K</pubmed_authors><pubmed_authors>Yang F</pubmed_authors><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Tao Z</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Lu Q</pubmed_authors><pubmed_authors>Tian Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Non-invasive prediction of fetal growth restriction by whole-genome promoter profiling of maternal plasma DNA: a nested case-control study.</name><description>&lt;h4>Objective&lt;/h4>To predict fetal growth restriction (FGR) by whole-genome promoter profiling of maternal plasma.&lt;h4>Design&lt;/h4>Nested case-control study.&lt;h4>Setting&lt;/h4>Hospital-based.&lt;h4>Population or sample&lt;/h4>810 pregnancies: 162 FGR cases and 648 controls.&lt;h4>Methods&lt;/h4>We identified gene promoters with a nucleosome footprint that differed between FGR cases and controls based on maternal plasma cell-free DNA (cfDNA) nucleosome profiling. Optimal classifiers were developed using support vector machine (SVM) and logistic regression (LR) models.&lt;h4>Main outcome measures&lt;/h4>Genes with differential coverages in promoter regions through the low-coverage whole-genome sequencing data analysis among FGR cases and controls. Receiver operating characteristic (ROC) analysis (area under the curve [AUC], accuracy, sensitivity and specificity) was used to evaluate the performance of classifiers.&lt;h4>Results&lt;/h4>Through the low-coverage whole-genome sequencing data analysis of FGR cases and controls, genes with significantly differential DNA coverage at promoter regions (-1000 to +1000 bp of transcription start sites) were identified. The non-invasive 'FGR classifier 1' (C&lt;sub>FGR&lt;/sub> 1) had the highest classification performance (AUC, 0.803; 95% CI 0.767-0.839; accuracy, 83.2%) was developed based on 14 genes with differential promoter coverage using a support vector machine.&lt;h4>Conclusions&lt;/h4>A promising FGR prediction method was successfully developed for assessing the risk of FGR at an early gestational age based on maternal plasma cfDNA nucleosome profiling.&lt;h4>Tweetable abstract&lt;/h4>A promising FGR prediction method was successfully developed, based on maternal plasma cfDNA nucleosome profiling.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2024-11-21T04:20:06.204Z</modification><creation>2021-02-21T04:19:01Z</creation></dates><accession>S-EPMC7818264</accession><cross_references><pubmed>32364311</pubmed><doi>10.1111/1471-0528.16292</doi></cross_references></HashMap>